Skip to main content
. Author manuscript; available in PMC: 2016 Jul 4.
Published in final edited form as: Pharmacoeconomics. 2012 Aug 1;30(8):697–712. doi: 10.2165/11597890-000000000-00000

Table VI.

Correlation between changes in dyad measures for clinically unstable patientsa

Change in questionnaire response Change in dyad HUI2 overall utility Change in dyad HUI3 overall utility
Dyad HUI3 overall utility 0.85# NA
Dyad PedsQL™ Core overall score 0.57*** 0.44*
Dyad PedsQL™ Asthma symptoms 0.45* 0.37*
Dyad PedsQL™ Asthma treatment 0.60*** 0.40*
PAQLQ activities 0.32 0.17
Dyad PAQLQ emotion 0.42* 0.41*
a

Point estimate represented by Spearman correlation coefficient. The analysis was performed on subjects who exhibited a clinically significant change between baseline and follow-up (n = 30). Clinically significant change was defined as a change in asthma severity classification by a physician and/or a change in the Asthma Control Questionnaire greater than 0.5.

HUI = Health Utilities Index; NA = not applicable; PAQLQ = Pediatric Asthma Quality of Life Questionnaire; PedsQL™ = Pediatric Quality of Life Inventory™;

*

p < 0.05,

***

p < 0.001,

#

p < 0.0001.